Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has reopened the claim for service connection for renal cell carcinoma with right nephrectomy due to new evidence received since the last denial. The Veteran's current diagnosis of renal cell carcinoma is presumed related to his in-service exposure to Agent Orange.

The deciding factor: New medical evidence provided by the Veteran established a current disability (renal cell carcinoma) and linked it to service, including exposure to herbicides like Agent Orange.

Claimed conditions
renal cell carcinoma with right nephrectomy
How they argued it
Reopened with new and material evidence
Exposure basis
Agent Orange / herbicides
Rating assigned
None in this decision
Decision date
June 24, 2010
Citation
1023577

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1023577.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.